ALLONasdaq GS

Allogene Therapeutics, Inc.

2.17+6.90%1d

Data as of Aug 25, 2026 · end-of-day snapshot

Volume signal tierC
Alert levelBaseline

Tier and alert level are a summary. Unlock ALLO to see the full accumulation read: relative-volume ratios, z-scores, money-flow and float turnover behind this signal.

+6.90%, upReturn · 1w
+24.00%, upReturn · 1m
−3.56%, downReturn · 3m
+87.07%, upReturn · 1y
−51.35%, well below its 52-week highvs 52-week high
Technicals

Technical readings

The latest end-of-day reading across momentum, trend and volatility signals, included free on every stock page.

Automated read

The moving-average structure shows no decisive trend in either direction: the mid-term picture reads as rangebound. RSI is currently 58.

RSI (14)57.93, favorable readingUpper-neutral
MACD / signal0.05 / 0.04, favorable readingAbove signal line
SMA 501.99, favorable readingPrice above
SMA 2001.93, favorable readingPrice above
EMA 202.04, favorable readingPrice above
ADX (14)16.01Rangebound
+DI / −DI25.11 / 16.55+DI leading
ATR (14)0.12, flagged reading5.8% of price — elevated daily swings
Stochastic %K80.65, flagged readingOverbought zone
Bollinger bands (20)1.80 – 2.24Inside bands
ROC (10)2.36, favorable readingPositive over 10 sessions
Trend / momentum impulseBoth rising, favorable impulse readingTrend and momentum agree

Readings as of Aug 25, 2026 · end-of-day snapshot

Full analysis

What unlocking ALLO reveals

Sample preview: figures are illustrative.

Company & theme write-up

Signal history

AI narrative

Catalysts & risks

Accumulation read

Unlock ALLO: full analysis
Free weekly sample report

Get a full sample stock analysis in your inbox every week, no card, just the same read you see here on one hand-picked ticker.

Earnings

When does Allogene Therapeutics, Inc. report earnings?

Allogene Therapeutics, Inc. (ALLO) is scheduled to report earnings on Nov 5, 2026.

The date is confirmed rather than estimated, though companies do occasionally reschedule.

Data as of Aug 26, 2026

See who else reports soon
Need the raw data?Get ALLO + ~22,000 stocks as a clean CSV: every column, ready to load into a spreadsheet or notebook.
Build a dataset
$9.90one-time Unlock ALLO